Statistics
Publications
79
Citations
8.4K
H-Index
43
Active since
1989
Markus Wartmann is an author at Novartis (Switzerland) specializing in pharmacology, medicine, and medicinal chemistry.
Publications per year
1989–2024
79
79
cPLA2 is phosphorylated and activated by MAP kinase
Lih‐Ling Lin, Markus Wartmann, Alice Lin et al. · Cell · 1993 · 1.9K citations
Vito Guagnano, Pascal Furet, Carsten Spanka et al. · Journal of Medicinal Chemistry · 2011 · 489 citations · Full text
CDK 4/6 Inhibitors Sensitize PIK3CA Mutant Breast Cancer to PI3K Inhibitors
Sadhna Vora, Dejan Juric, Nayoon Kim et al. · Cancer Cell · 2014 · 439 citations · Full text
Medicine, Cancer Biology, Oncology +14
Peter Traxler, Peter R. Allegrini, Ralf Brandt et al. · Cancer Research · 2004 · 318 citations
Medicine, Oncology, Pharmacology +17
1–5 of 79